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Introduction
his brief review will focus on rodent (rat and
mouse) models of anxiety disorders. There are of course
models of anxiety disorders in other species, including
nonhuman primates,
1 but rat and mouse models are by
far the most commonly used in the current preclinical
and psychiatric (genetic) research. Our aim is not to pre-
sent an exhaustive view of all existing models, but to dis-
cuss some conceptual issues related to these models.
A first and important issue is whether various animal
species can really be used as “models” of human
pathologies, given the highly subjective nature of anxi-
ety. Do animals experience something like human anxi-
ety, and how can we measure it, since we cannot “think
like a rat”?
2 We will argue that, as mentioned by many
authors, the behavioral responses and brain mechanisms
associated with an “anxious state” are so essential for
survival that they must have evolved very early in the
development of mammalian species and are probably
highly conserved—the phylogenetic argument.
3 In view
of the relationship between anxiety and coping styles, or
of the pivotal role of fear-conditioning processes (to be
developed in the following sections), it is not unlikely
that some form of anxiety exists in other vertebrate
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Animal models can certainly be useful to find out more
about the biological bases of anxiety disorders and
develop new, more efficient pharmacological and/or
behavioral treatments. However, many of the current
“models of anxiety” in animals do not deal with pathol-
ogy itself, but only with extreme forms of anxiety which
are still in the normal, adaptive range. These models
have certainly provided a lot of information on brain
and behavioral mechanisms which could be involved in
the etiology and physiopathology of anxiety disorders,
but are usually not satisfactory when confronted directly
with clinical syndromes. Further progress in this field will
probably depend on the finding of endophenotypes
which can be studied in both humans and animals with
common methodological approaches. The emphasis
should be on individual differences in vulnerability,
which have to be included in animal models. Finally,
progress will also depend on refining theoretical con-
structs from an interdisciplinary perspective, including
psychiatry, psychology, behavioral sciences, genetics, and
other neurosciences. 
© 2011, LLS SAS Dialogues Clin Neurosci. 2011;13:495-506.
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capacity to detect danger and react to threat.
4 This may
offer new opportunities to design as-yet unexpected
models.
5-8 The probability of finding the various emo-
tional responses and “logistic systems” involved in anx-
iety across phyla is discussed in a recent review.
9
Some of the other issues that we would like to discuss
here are the following: (i) How does anxiety relate to
individual stress/fear coping strategies, and how are
these determined? (ii) Do anxiety disorders arise from
the failure to adapt successfully to life challenges (the
maldaptation or dysadaptation hypothesis), and/or do
they have more distant causes? (iii) What is the relative
importance of genetic/epigenetic factors and life events
in determining increased or decreased individual vul-
nerability to anxiety disorders? (iv) How accurately can
animal models predict the efficacy of pharmacological
or other kinds of treatments, and help in the develop-
ment of new therapeutic approaches?
We believe that some of the existing animal models of
anxiety disorders have been or will be able to provide
important information regarding these issues. However,
in order to do so, these models will have to be perma-
nently confronted with clinical practice, and also under-
stood and discussed by clinicians. This is an absolute pre-
requisite for a successful translational approach. 
Anxiety and its disorders
Anxiety is usually described as “a psychological, physi-
ological, and behavioral state induced in animals and
humans by a threat to well-being or survival, either
actual or potential.”
10 It is characterized by increased
arousal, expectancy, autonomic and neuroendocrine acti-
vation, and specific behavior patterns, often with a
behavioral transition from ongoing behaviors (eg, explo-
ration, feeding) to an escape (eg, flight) or other defen-
sive behaviors. The function of these changes is to facil-
itate coping with an adverse or unexpected situation.
However, if the adaptive function of anxiety is not suc-
cessful, anxiety can become a pathological state, which
may later on interfere with the ability to cope with var-
ious challenges or stressful events in daily life, and even
alter body condition. Pathological anxiety can also be a
consequence of predisposing factors (or traits), which
result from numerous gene-environment interactions
during development (particularly during the perinatal
period), and experience (life events). Conceptually, it is
important to distinguish fear, which is a response to an
immediate, real danger, from anxiety, which is a response
to threat, ie, a potential danger.
10
Threat and coping strategies
The term “coping” refers to physiological, psychological,
and behavioral responses aimed at avoiding harm or dis-
tress, is conceptually more or less equivalent to “defense
mechanisms,” and applies to both humans and animals.
11,12
Coping mechanisms are clearly important for health and
disease; a proper, successful coping strategy decreases the
impact of stress and protects the organism from its long-
term consequences. It is more and more evident that vul-
nerability to stress-induced diseases is highly individual
and may in part depend on coping styles. A coping style
can be defined as: “[…] a coherent set of behavioural and
physiological stress responses which is consistent over
time and which is characteristic to a certain group of indi-
viduals.” 
11 Coping styles are more or less comparable to
“temperament” or “personality” traits in humans, and
form the basis of individual differences, which are essen-
tial to maintain the species’ (or population’s) adaptive
capacity under changing environmental conditions.
13The
genetic, epigenetic, and learned aspects of individual cop-
ing style are still a matter of debate. Individuals can be
broadly classified into two categories: the active (or
proactive) copers, and the passive (or reactive) copers;
within each category of coping style, there is still ample
space for large interindividual variability. As far as ani-
mal models are concerned, we have suggested using the
concept of “psychobiological profile” to characterize indi-
vidual sets of particular physiological and behavioral
parameters, and to categorize individuals.
14 Indeed, for
a long time, researchers have tried to avoid or ignore the
problem of interindividual differences in groups of exper-
imental animals, especially when designing animal mod-
els. This apparent “homogeneity” was even an argument
to use animals rather than human subjects! However, it
is now clear that such differences do exist and are impor-
tant, particularly as regards translational studies in psy-
chiatry. For instance, the search for vulnerability (or pre-
disposition) factors requires tools to describe these
individual differences adequately. Guidelines for defin-
ing personality differences in rats have been recently pro-
posed.
15Two theoretical models more directly related to
individual differences in stress coping in rodents have
also been published.
16,17
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As shown in Figure 1, there are two main, alternative
strategies to face environmental and/or psychosocial
challenges, or threat.
18 One is a passive (or reactive)
strategy (conservation/withdrawal) aimed at protect-
ing the organism from the possible consequences of
threat, as originally described by Engel and Schmale.
19
The other one is an active (or proactive) strategy
aimed at eliminating the source of threat, either by
escaping (“flight”) or facing it (“fight)”, originally
described as the “fight-or-flight” response by Walter
Cannon.
20The physiological responses associated with
these alternative strategies are described in Henry’s
account of how individuals may adapt under threat sit-
uations: 
The sympathetic-adrenal medullary system (SAM) is acti-
vated when the organism is challenged but remains in con-
trol. With the increasing perception that loss of control and
helplessness may occur, there is activation of the hypothal-
amic–pituitary–adrenal (HPA) axis and the oxytocin-
gonadotrophic species preservative system shuts down.
There is a shift from active defense to a passive nonaggres-
sive coping style. The emphasis is now on “self-preservation.
21
Figure 1. Alternative defense (coping) strategies in response to threat. Depending on their psychobiological profile (temperament), previous expe-
riences, appraisal of the situation, and/or environmental constraints, individuals can choose between an active fight-or-flight strategy, or
a more passive, conservative-withdrawal response. If flight is not possible (“entrapment” situation, see ref 22) or aborted (“Arrested flight,”
see ref 23), they have to rely on a passive coping strategy. The same occurs if, after fighting, they are defeated. Anxiety is markedly increased
when the more passive coping strategies are used, or when action is inhibited, even momentarily (in choice and/or conflict situations). See
text for details.
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Thus, there are many situations where individuals can
use alternative coping strategies (Figure 1). The choice
will depend on their constitutive psychobiological pro-
file (individual coping style, or temperament, see above),
previous experience, appraisal of the situation and/or
environmental constraints. If escape (flight) is not pos-
sible, as in an “entrapment” situation,
22 or aborted—the
“arrested flight”—,
23 individuals will have to rely on a
passive coping strategy. The same occurs if, after fight-
ing, they are defeated.
22 As shown at the bottom of
Figure 1, anxiety is markedly increased when the more
passive coping strategies are used, or when action is
inhibited, even momentarily (in choice and/or conflict
situations). However, if some kind of action can be
undertaken, even under conditions of restricted choice,
a blunting of the physiological, anxious response can be
observed. If rats subjected to inescapable electric shocks
can start fighting with a partner, if rats tightly restrained
(immobilization stress) can bite a piece of wood,
24 or if
rats exposed to a novel situation perform self-grooming
(a displacement activity), all these actions decrease the
impact of stress and associated anxiety. Displaced
aggression probably has a similar function.
25Anxiety dis-
orders are characterized by the avoidance of situations
that can lead to the arousal of fear and anxiety. Passive
avoidance is part of some disorders; if it can be turned
into an active coping strategy (at the cognitive and/or
behavioral level), then things are much better off.
26
Turning passive into more active coping strategies is
indeed the basis of many cognitive-behavioral therapies,
which are probably among the most effective interven-
tions regarding a number of anxiety disorders. 
The inhibition of ongoing behavior is one of the first
behavioral symptoms of an anxious or fearful state. In
the 1970s, Jeffrey Gray suggested that vulnerability to
anxiety is associated with individual differences in the
activity of a septo-hippocampal “behavioral inhibition
system,” or BIS.
27 Anxiety reflects a central state medi-
ated by BIS activation, which is elicited by threats of
punishment or failure, and by novelty or uncertainty. The
results of BIS activation are an inhibition of the ongoing
behavior, increased arousal and attention to environ-
mental stimuli, especially novel stimuli.
28 A number of
human studies, in both community samples and clinical
groups, have indicated that anxiety symptoms generally
show positive associations with BIS sensitivity.
29 Gray’s
Reinforcement Sensitivity Theory (RST), which has
been revised and adapted many times,
30 may thus not
only be a good framework for research on personality-
psychopathology associations,
29 but also for translational
studies, because of its relevance for animal behavior and
natural defence mechanisms.
The central role of behavioral inhibition in generating
an “anxious state” has also be pointed out by Laborit.
31
For this author, anxiety is associated with the “alarm
reaction,” as defined in Selye’s original description of the
stress response (or general adaptation syndrome).
32
Anxiety appears when one realizes that a proper adap-
tive action is not possible, ie, that there is loss of control
over the situation, and it involves an activation of the
HPA axis. 
According to Panksepp,
33 the two opposite, spontaneous
behavior patterns (ie, freezing, crouching, and passive
avoidance, or flight, escape and active avoidance) seen
in the response of animals to threat may have distinct
and successive roles. Flight and other active coping
behaviors are unconditional responses to proximate
threat, whereas passive coping strategies such as freez-
ing are conditioned responses to distal stimuli predictive
of danger. These strategies are modulated by the (cog-
nitive) apprehension of the environment and probabil-
ity of success, eg, whether or not there is a route of
escape. Thus, when an animal faces a predator, freezing
is preferentially activated when the source of known
danger is still far away. When danger gets closer, and the
stimulus passes through some critical “psychometric”
distance, it becomes a true unconditional stimulus and a
flight pattern is activated.
34
Coping strategies provide a new, interesting theoretical
framework for models investigating the role of individ-
ual differences in vulnerability to anxiety disorders, and
their genetic and epigenetic determinants.
Fear conditioning
Learning the relationships between aversive events and
environmental stimuli which predict these events is
essential for survival. The neurobiological bases of fear
conditioning have been extensively investigated during
the last decades.
35,36The major aspects of the relationship
between conditioned fear and anxiety are the fact that a
fearful response can be associated with specific cues
(conditional stimuli, CS), and that this learned associa-
tion can be “unlearned,” ie, not forgotten, but actively
repressed.
37This fear conditioning (or learned fear) par-
adigm is highly relevant for some anxiety disorders, eg,
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particular, and is used in several animal models. The crit-
ical stage appears to be not the training (conditioning)
phase, when the conditional (CS) and unconditional
(US) stimuli are presented in a meaningful temporal
relationship, but the extinction phase, when the CS is
presented alone (without the reinforcement stimulus),
during the time necessary for extinction to occur; some
individuals fail to repress the memory of fear and show
all the behavioral and physiological signs normally trig-
gered in the presence of an actual threat. 
Thus, fear conditioning provides another relevant the-
oretical framework for translational studies on anxiety
disorders.
Conflict
Motivational conflict 
This can be a major source of anxiety. Indeed, making
a wrong decision in the face of danger can be fatal, and
having to decide on the right way of doing constitutes
a form of “psychological threat.” More frequently, the
consequences of a wrong choice are not life-threatening,
but can change an inidividual’s life (losing one’s partner,
territory, or social status), or be only unpleasant (being
momentarily deprived of food). In any case, making a
decision when the consequences are unpredictable is a
source of stress.
Frustration
Frustration can also be a source of anxiety, could be con-
sidered as a particular form of conflict. Frustration
occurs when there is a discrepancy between the expected
and actual outcome of an action. For instance, if you
train animals to reach a goal by obeying certain rules,
and then change the rules, they get very upset and enter
a motivational conflict. This situation is very frequent in
humans, and can lead not only to various anxiety disor-
ders, but also to depression. 
Conflict situations are present, directly or indirectly, in
most animal models of anxiety. Thus, during exploration
of a novel environment (a situation encountered in
many of the tests), there is always a conflict between
curiosity (knowing more about it) and fear (how risky is
it?). In rats, this conflict may be displayed in the form of
a displacement activity such as self-grooming.
38
Memories and anticipation
The capacity to remember past events and situations
(particularly frightful or traumatic ones), and to antic-
ipate them, parallels the development of the cortico-
limbic system during evolution. Higher mammals,
including humans, are thus better able to integrate past
experiences and to “prepare for the worst.” This is an
obvious adaptive advantage, but it also has severe
drawbacks if the mechanisms involved are not con-
stantly adjusted to “the real world.” It seems quite
clear that some forms of anxiety disorders are a direct
consequence of this (in)capacity to take into account
past and future events. Generalized Anxiety Disorder
(GAD) is probably linked to a bias in anticipating
adverse circumstances (often without any obvious
threat), whereas PTSD certainly results from a deficit
in repressing traumatic memories. This is also the case,
on a more elementary level, for various kinds of pho-
bic disorders, although some of these may be associ-
ated with more primitive, species-related fear memo-
ries.
39,40
Individual differences in coping styles, and in the capac-
ity to deal with learned fear, conflict, fear memories, and
anticipation of adverse events are thus the most impor-
tant factors determining vulnerability to anxiety disor-
ders. Genetic and epigenetic predisposition factors do
also play an important role, either per se or in combina-
tion with the above.
41
In the following sections, we will see how and to what
extent these concepts are applied in various animal mod-
els of anxiety disorders. 
Trait vs state anxiety
Reference is sometime made to two sorts of anxiety:
“state” anxiety is experienced at a particular moment
and is enhanced by anxiogenic stimuli, whereas “trait”
anxiety does not vary over time and is an innate char-
acteristic of an “anxious” individual.
42,43 These defini-
tions are certainly open to criticism: it seems difficult
to assess trait anxiety in the absence of anxiogenic
stimuli, and these stimuli also increase anxiety in “nat-
urally anxious” individuals… However, rat and mouse
lines selected for high anxiety (see below) certainly
present a form of “trait” anxiety. Trait anxiety is sup-
posed to be a predisposing factor for anxiety disor-
ders.
499
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Anxiety disorders: a dysadaptation hypothesis
The mismatch hypothesis and the concept of adaptive
phenotypic plasticity have been recently proposed in the
context of animal models of depression in order to
explain why some individuals may develop depression-
like symptoms in adulthood when exposed to chronic
stress in early life, while others do well or even better.
44
A similar concept could be applied to models of anxiety
disorders, where early life events have also been shown
to influence the anxious phenotype. Thus, rat pups born
from mothers having been stressed during pregnancy
tend to be more anxious than their counterparts raised
by non-stressed mothers.
45-47 This phenomenon, called
adaptive phenotypic plasticity, which has a limited range,
or “norm of reaction,” 
48 is the basis for Darwinian fit-
ness
49 and is mediated in part by epigenetic mechanisms:
gene expression is modulated to fit the most probable
environmental demands during the lifetime of the indi-
vidual.
50 Mismatch occurs when the expected conditions
are not met in later life, eg, when early adverse condi-
tions increase the sensitivity of the stress-response sys-
tems and when this hypersensitivity remains even when
environmental pressure becomes lower in adulthood.
Indeed, most individuals seem to adapt to this type of
change in environmental conditions (a phenomenon
known as “resilience”), but a few fail to do so—a situa-
tion which is somehow reminiscent of what is observed
in fear conditioning when extinction of learned fear does
not occur, as described above. For this reason, it has been
recently proposed that the basis for vulnerability to dis-
ease could involve genes (yet to be discovered) that
would be responsible for different forms of brain and
behavioral plasticity.
51 Behavioral flexibility is a form of
plasticity that may favor optimal coping
17,48 and therefore
decrease the risk of developing a pathology—or increase
resilience, a phenomenon that certainly deserves more
attention in future studies.
The term “dysadaptation” has been used previously in
ophtalmology to describe “[…] the inability of the retina
and iris to accommodate well to varying intensities of
light.” 
52 By analogy, this term could be applied to anxiety
disorders, inasmuch as it would describe “the inability of
defence/coping mechanisms to adapt to varying degrees
of threat,” or the individual’s inability to evaluate cor-
rectly the risks actually associated with signals of danger
(perceived threat). The term “dysadaptation” seems to
be better suited than “maladaptation,” in the sense that
the psychophysiological and behavioral responses are still
potentially adaptive, but inappropriate to the context, or
the situation (the mismatch hypothesis). 
Animal models and tests
What is a model?
In biomedical research, a model is usually described as
an experimental setup or protocol (sometimes also
called “a paradigm”) developed in a nonhuman species
with the aim of replicating humans physiological, patho-
physiological, or behavioral features. In other scientific
disciplines (eg, mathematics or physics), the term
“model” usually refers to a theoretical construct from
which specific hypotheses can be deduced and tested
experimentally. Animal models of psychiatric disorders
can belong to both categories. The most simple models,
notably those aimed at testing psychotropic drugs or
other treatments— “empirical validity models”
53—often
have a limited, if any, theoretical background. This is also
the case for those developed to simulate a specific sign
or symptom (“Behavioral similarity models”). However,
“theory-driven” and “mechanistic” models (according to
McKinney’s terminology), in particular those developed
to study etiological aspects and/or the neurochemical
and genetic mechanisms underlying anxiety disorders,
often have an elaborate theoretical background. 
How do we measure anxiety in animals?
The only variables that can be observed and measured
in animals are the behavioral and physiological
responses elicited when they are exposed to more or less
naturalistic, potentially anxiogenic situations under con-
trolled laboratory conditions. Setup and protocols used
to record these experimental data are usually called
“tests,” and constitute instruments (or tools) to measure
anxiety-related parameters. It should be mentioned that,
in the animal research literature, particularly as regards
the so-called preclinical (pharmacological) studies, the
term “model” is often used abusively to characterize a
test, ie, a particular experimental setup (eg, “The ele-
vated plus-maze as a model of anxiety in rodents”!). This
usage should be avoided, because it is misleading: a
model in the true sense has a more elaborate theoretical
background and may include several tests. In the fol-
lowing section, we will mention a few examples of
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(mainly ethological) anxiety tests for rodents, which are
by far the most common species used as animals models
nowadays. There are over 30 different procedures (and
many variations) described in the literature, with two
main categories: unconditioned response tests (which
require no training and usually have a high eco/etho-
logical validity) and conditioned response tests (which
often require extensive training and may show interfer-
ence with mnemonic and motivational processes).
54 A
few examples are shown in Table I. More information
regarding practical aspects of testing can be found in the
literature
55-58 and in the references in Table I.
Although measurements can be done using a single test,
it is better to use a battery of these tests (for instance, the
open field, the EPM, and a dark/light transition test) to
assess each individual’s behavioral phenotype, since
these tests measure anxiety under different conditions.
59
Data obtained from different tests can be combined to
create “derived” variables which offer a more complete
description of the individual behavioral profiles.
14 Other
elaborate forms of data analysis can (and should) be
used: factorial analysis,
60,61 structural analysis,
62 or multi-
variate (principal component) analysis.
63 Some of these
tests are time-consuming, and therefore not always
appropriate for large screening studies, but the through-
put of behavioral assessment has been markedly
improved in recent years by the use of automated mon-
itoring, computer data processing, and the development
of dedicated software for behavioral analysis.
64
How can we assess the validity of models?
In the mid 1980s, Willner proposed three sets of crite-
ria for assessing animal models of human mental disor-
ders: predictive validity (performance in the test predicts
performance in the condition being modeled), face valid-
ity (phenomenological similarity), and construct validity
(theoretical rationale).
65,66
To these “classical” criteria, we would like to add a new
one, recently proposed by Mathias Schmidt in the con-
Unconditioned responses ("ethological" models) Refs Conditioned responses Refs
Exploratory behavior Conflict tests
Open field(s) 97 Geller-Seifter 98
Elevated Plus Maze (EPM) 99;100 Vogel 101,102
Elevated T-Maze 103
Zero-Maze 104
Holeboard(s) 105
Free exploration paradigm 106
Dark/light transition Avoidance tests
Black/white box 107,108 Passive avoidance 109
Dark/light open field 16 (Two-way) Active avoidance 110
Social behavior Inhibitory avoidance (Elevated T-Maze) 111,112
Separation-induced US vocalizations (pups) 113
Stress-induced vocalization (adults) 114
Social interaction 115 Fear-potentiated behavior in the EPM 116
Antipredator/defence
Anxiety test battery 59 Defensive (probe or prod) burying 117,118
Mouse defence test battery 119
Predator odor avoidance 120
Others
Hyponeophagia 121
Open field drink test (OFDT) 122 Conditioned suppression 56
Startle response (baseline) 123 Fear-potentiated startle (FPS) 56
Freezing (unconditioned) (SNT) 124 Conditioned emotional response (CER) 56
Stress-induced hyperthermia (SIH) 79
Table I. Models or tests of anxiety in rodents. For a definition of tests vs models, see text. See also refs 95, 96. 
Adapted from ref 54: Rodgers RJ. Animal models of 'anxiety': where next? Behav Pharmacol. 1997;8:477-496. Copyright © Lippincott Williams and Wilkins 1997
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validity” criterion.
44 This is a specific extension of the
“face validity” criterion: the occurrence rate of a disease-
like phenotype in an (epi)genetically heterogeneous
population should match the human situation (same
odds ratio for that risk or predisposition factor). Thus,
risk factors such as adverse early life events should only
affect a subpopulation of more vulnerable individuals.
Application of this criterion poses a number of prob-
lems, notably regarding the number of animals which
have to be used. However, the occurrence of anxiety dis-
orders is quite frequent (lifetime prevalence 15% to
30%) in the general population,
67,68 and similar values
can be expected in a rat or mice population, as this has
been shown for instance in animal models of PTSD.
69
It would seem that application of the population valid-
ity criteria is probably essential if we want to develop
models of anxiety disorders, and not only models of anx-
iety within the “reaction norm” (ie, in the normal adap-
tive range), although these models are still useful to
delineate the biological and neural mechanisms under-
lying “normal” anxiety, or to evaluate the efficacy of
(pharmacological) treatments.
Should models be based on clinical symptom 
classification?
In our views, the obvious answer to that question is: no, or
at least not exclusively. First, the classifications of psychi-
atric diseases (either with the DSM-IV or ICD-10 systems)
remain essentially syndromic and is constantly being
revised.
70,71 Second, currently recognized categories of psy-
chiatric disorders include heterogeneous populations of
patients, with subpopulations featuring a great diversity in
underlying (epi)genetic and other predisposition factors,
neurobiological mechanisms, life history, and comorbidi-
ties. And third, some important aspects of human pathol-
ogy will probably never be accessible in animal models (eg,
sadness or suicidal ideation in depression). However, some
symptoms found in anxiety disorders can probably be
modeled quite accurately in rats or mice.
72
Recent advances suggest that translational research
should preferably be based on “functional modules,” or
particular sets (or patterns) of psychophysiological and
behavioral responses related to coping with stress, fear,
and anxiety, not on psychiatric symptoms as such. These
functional modules correspond to specific neural circuits,
hormonal systems, and behavioral/psychophysiological
responses which are found both in humans and our
existing animal models. These modules are conceptually
equivalent or similar to what has been described as
“endophenotypes” in neurogenetic research.
73,74The con-
cepts of “endophenotype” (as opposed to “exopheno-
type”) was originally proposed by John and Lewis to
describe features that were “…not the obvious and
external but the microscopic and internal.”
75 In
Gottesman’s own words: 
Development of animal partial-models in psychiatry relies
on identifying critical components of behavior (or other neu-
robiological traits) that are representative of more complex
phenomena. Animals will never have guilty ruminations, sui-
cidal thoughts, or rapid speech. Thus, animal models based
on endophenotypes that represent evolutionarily selected
and quantifiable traits may better lend themselves to inves-
tigation of psychiatric phenomena than models based on
face-valid diagnostic phenotypes.
73
How can we define endophenotypes for anxiety?
As compared with other psychiatric disorders (eg, schizo-
phrenia), only a few endophenotypes for anxiety have
been proposed so far.
74Among them, two at least can be
assessed in animal models. One is HPA axis activation and
other parameters associated with an inhibited (fearful)
temperament.
76The other one is also linked to personality
characteristics: trait anxiety (anxious temperament) and
behavioral inhibition.
77These endophenotypes emphasize
the major role played by coping strategies in individual
vulnerability or resilience to anxiety (and other) disorders.
Other, more psychophysiological endophenotypes that
have been suggested are CO2 sensitivity for panic disor-
der,
78 stress-induced hyperthermia (SIH), which is found
across numerous species, including humans, and reflects
SAM activation,
79 and the startle response, which is also
found in humans and various species.
80
Further progress in the field of animal models of anxi-
ety will certainly rely heavily on discovering and vali-
dating more endophenotypes, in particular those related
to individual brain and behavioral plasticity, and the
capacity to adapt to stressful experiences. 
What are the current trends 
in animal models?
Although there is still a need for better and more reli-
able animal models for screening potential therapeutic
Translational research
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“face and construct validity” models to study the etiol-
ogy and underlying neurobiological mechanisms of anx-
iety disorders, in particular for psychiatric genetic
research. Trait anxiety (the “anxious temperament”),
supposed to be a major risk factor for anxiety disorders,
81
is found in a number of individuals in a normal rat or
mice population, but is easier to study in lines obtained
by (psycho)genetic selection, where expression of this
trait is enhanced. A number of rat lines have been pro-
posed as models of trait anxiety: The HAB rats,
82
selected on the basis of their behavior in the EPM; the
Syracuse rats
83; the Maudsley reactive/nonreactive
strains
84; the Tsukuba
85 and Floripa
86 lines; and two lines
selected on the basis of pups’ ultrasonic vocalizations.
87
The Roman Low-Avoidance (RLA) rats, selected on the
basis of poor acquisition of a two-way avoidance
response in the shuttle box, can also be considered as a
model of high trait anxiety-emotionality.
14,88-91A number
of mouse lines are also available.
72 Selective breeding of
rats and mice improves the probability of discovering
anxiety-related neurobiological correlates,
92 including
genetic determinants, and allows the study of gene-envi-
ronment interactions. Finding out how these gene-envi-
ronment interactions (and associated epigenetic and psy-
chophysiological/behavioral mechanisms) determine
each individual’s capacity to cope with fear, threat and
stressful situations appears to be a major goal of animal
models in the years to come. 
As regards the genetic bases of vulnerability to anxiety
disorders, many different approaches are being used,
apart from using selected lines. These include targeted
manipulation of candidate genes (eg, generation of
knockout or transgenic animals), siRNA and viral trans-
fection, quantitative trait loci (QTL) analysis, and the
use of gene expression arrays, among others.
72
A relatively new field in animal models of anxiety dis-
orders is the study of structural brain plasticity and adap-
tive neurogenesis, which appears to be involved in anx-
iety-related behaviors.
93
Summary and conclusions
In 2001, the National Institute of Mental Health
(NIMH) organized a workshop to discuss the relation-
ship between existing behavioral models of anxiety and
the clinical profile of anxiety disorders. The conclusions
were not too optimistic:
The probability of developing comprehensive animal mod-
els that accurately reflect the relative influences of factors
contributing to anxiety disorder syndromes is quite low.
However, ample opportunity remains to better define and
extend existing models and behavioral measures related to
specific processes that may be disrupted in anxiety disorders,
and to develop new models that consider the impact of com-
bined factors in determining anxious behaviors.
94
What is the situation like almost 10 years later?
Indeed, the last decade has seen some major conceptual
progress. First, the primary importance of individual dif-
ferences in personality, temperament, or coping style as
regards vulnerability to various anxiety disorders has been
recognized, not only in psychiatry, but also in animal mod-
els. This means taking into account genetic and epigenetic
factors, life events, and response and adaptation to stress-
ful situations (“life trajectories”) in future models. Second,
some recent discoveries have also indicated an important
role for behavioral flexibility and adaptive (neural) plas-
ticity. This suggests that some disorders may result from a
deficit in various forms of brain and behavioral plastic-
ity and perhaps depend, at least in part, on altered neu-
rodevelopmental processes. Application of new, stricter
validation criteria, such as the “population validity” crite-
rion, will be required to ensure the “face validity” of these
future models and help discriminating between extreme
forms of anxiety and truly pathological ones. 
One issue that remains unsettled is the following: how
accurately can existing or future animal models predict
the efficacy of pharmacological or other kinds of treat-
ments, and help in the development of new therapeutic
approaches? It is likely that the answer will depend not
only on the intrinsic validity of the models, but also on
refining diagnostic criteria for anxiety disorders, which
will have to be based at least in part on the description
of relevant endophenotypes. This implies a bidirectional
exchange of information and hypotheses between clin-
icians and neurobiologists, which is after all the true
essence of translational research. 
In conclusion, we believe that the future lies in the
development of models based on individual vulnerabil-
ity to anxiety disorders, particularly in relation to
genetic/epigenetic determinants, life events and condi-
tioned fear responses, and coping strategies.  ❏
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Modelos animales de los trastornos 
ansiosos en ratas y ratones: algunos temas
conceptuales
Ciertamente los modelos animales pueden resultar
útiles para descubrir más acerca de las bases biológi-
cas de los trastornos ansiosos y desarrollar nuevos y
más eficientes tratamientos farmacológicos y/o con-
ductuales. Sin embargo, muchos de los actuales
“modelos de ansiedad” en animales no abordan lo
patológico propiamente tal, sino que sólo formas
extremas de ansiedad que están en un rango normal,
adaptativo. Realmente estos modelos han provisto de
bastante información sobre los mecanismos cerebra-
les y conductuales que podrían estar involucrados en
la etiología y fisiopatología de los trastornos ansiosos,
pero habitualmente no resultan satisfactorios cuando
se confrontan directamente con los síndromes clínicos.
Los futuros progresos en este campo dependerán pro-
bablemente de hallazgos de endofenotipos que pue-
dan ser estudiados tanto en humanos como en ani-
males con abordajes metodológicos comunes. El
énfasis debe colocarse en las diferencias individuales
de la vulnerabilidad, lo que tiene que estar incluido
en los modelos animales. Finalmente el progreso tam-
bién dependerá del refinamiento de los constructos
teóricos desde una perspectiva interdisciplinaria, que
incluya la psiquiatría, la psicología, las ciencias de la
conducta, la genética y otras neurociencias.  
Modèles animaux de troubles anxieux chez
les rats et les souris : quelques problèmes
théoriques
Les modèles animaux se sont montrés utiles pour
étudier les bases biologiques des troubles anxieux
et pour développer de nouveaux traitements, phar-
macologiques ou mêmes comportementaux.
Cependant, la plupart des modèles actuels ne
concernent pas directement la pathologie, mais
seulement des formes extrêmes d’anxiété, qui res-
tent toutefois dans une norme permettant l’adap-
tation. Ces modèles ont certainement donné une
quantité d’informations sur les mécanismes nerveux
et comportementaux qui pourraient être impliqués
dans l’étiologie et la physiopathologie des troubles
anxieux, mais ne sont pas toujours satisfaisants lors-
qu’ils sont confrontés à la réalité clinique. Le pro-
grès dans ce domaine va dépendre de la découverte
d’endophénotypes qui pourront être étudiés chez
l’homme et chez l’animal avec des approches
méthodologiques communes. Les différences inter-
individuelles dans la vulnérabilité doivent aussi être
prises en compte dans les modèles animaux.
Finalement, le progrès dépendra également d’une
approche interdisciplinaire des bases théoriques de
l’anxiété, approche qui devrait impliquer non seu-
lement la psychiatrie et la psychologie, mais aussi
les sciences du comportement et les neurosciences.
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